AUROPHARMA
Auro Pharma : Range BuyAuro Pharma is trading in the range shown by trendline on chart. It has bounced 3 times (up arrow) from the support line of consolidation zone. RSI is also in oversold territory and has rebound from below 20 to above 20. Any correction towards 695-690 range can be used to initiate buy position with stop loss below 668 for target 732- 755 on up side.
AUROPHARMA* On the daily chart stock price has decisively broken out from its multiple resistance zone of 822 - 830 levels on closing basis and sustaining above the same.
* This breakout is accompanied with increase in volume which supports bullish sentiments ahead.
* The daily as well as weekly strength indicator RSI and the momentum indicator Stochastic both are in positive territory which supports upside momentum to continue in near term.
* Stock price is sustaining well above its 20,50 and 100 day SMA which supports bullish sentiments ahead.
* The above analysis indicate an upside of 864.50 - 881 with stop loss 800
#Findyourtrade
Aurobindo Pharma jumps 3% | Trade Nivesh Trade NIvesh : Pharma shares were trading higher in Friday's morning session with their sectoral index trading higher.
if you want to make position in future market BUY AUROPHARMA FUTURE ABOVE 826 TG 850, 880 SL 812
Go Long Auro Pharma (End of Series)Good opportunity on Auro Pharma seems to be consolidating out of a correction
Hurdle 870, good for long term investors also.
consolidationTHERE IS A CLEAR BREAKOUT FROM A TRIANGLE PATTERN AND SMALL CONSOLIDATION IN A WEDGE LIKE STRUCTURE
LET IT BREAK THE CONSOLIDATION FOR A BULL MARKET
REFER CHART FOR DETAILS
Auropharma Inside A Box.Greetings friends. I'm excepting the market to reach a level of 567 If it breaks the box. If not, buy and it's target is the previous upper box level. Make sure you catch it. Hope y'll find this useful. G'day guys.
RISKY BUY AUROPHARMA || SL-748Buy Auropharma on a minor dip with a SL of 748 and target of 772. Do not take a trade if it opens above 767. #intraday
Adjust trading volumes as per entry price.
Disclaimer :
All investments involve risk, and the past performance of a security, industry, sector, market, financial product, trading strategy, or individual’s trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. Any opinions, news, research, analyses, prices, or other information offered is provided as general market commentary, and does not constitute investment advice. I will not accept liability for any loss or damage, including without limitation any loss of profit, which may arise directly or indirectly from use of or reliance on such information.
